About
Katie Wraith is a Lecturer in Cardiovascular Biology at the Hull York Medical School (University of Hull). She leads a laboratory investigating platelet and coagulation pathway dysregulation in cardiovascular diseases, with a focus on oxidized low-density lipoproteins (oxLDL).
- Education: PhD in Medical Sciences (2013, Hull York Medical School)
- Career: Post-Doctoral Research Assistant (2013-2017, Naseem Lab); Senior Laboratory Research Scientist (2022-2024, Palmer Lab); Lecturer since 2024
Research Interests: Her work explores how oxLDL amplifies platelet activation and pro-coagulant responses in diseases like atherosclerosis. Key areas include thrombosis mechanisms, lipid metabolism, and signal transduction pathways.
Recent Article Trends: Analysis of her publications (2013-2025) reveals consistent focus on oxLDL interactions with platelet receptors (CD36, αIIbβ3), hypoxia effects on platelet function, and dyslipidemia-induced hyperactivity mechanisms. Subfields include antiplatelet therapies, thrombin signaling, and fibrinogen modulation.
Teaching: Delivers the Haemostasis and Thrombosis in Cardiovascular Diseases module for MB BS Medicine. Leads independent research projects across Biomedical Science and Health & Climate Change programs.
Projects: Principal investigator for the MRC-funded RISE project (2024-2029) establishing super-resolution imaging for multimorbidity research.
